Ruderman Eric M
Bull Hosp Jt Dis (2013). 2013;71(3):214-7.
The treat to target approach to managing therapy in rheumatoid arthritis was only just formally proposed in 2010, yet it is clearly here to stay. While the original recommendations were based on a limited set of published data, subsequent studies have explored the role of the treat to target approach in a variety of clinical settings and have confirmed its value. Despite this, additional data is needed, and challenges still remain in the widespread implementation of the treat to target strategy. Some of these challenges are at the patient level, some are at the physician level, and some are at the system level. The identification of these challenges is in itself an opportunity to improve the treat to target paradigm in order to maximize the outcomes of patients with rheumatoid arthritis.
类风湿关节炎治疗的达标治疗方法直到2010年才正式提出，但显然它会持续存在。虽然最初的建议基于一组有限的已发表数据，但后续研究探讨了达标治疗方法在各种临床环境中的作用，并证实了其价值。尽管如此，仍需要更多数据，并且在广泛实施达标治疗策略方面仍然存在挑战。其中一些挑战存在于患者层面，一些存在于医生层面，还有一些存在于系统层面。识别这些挑战本身就是一个改进达标治疗模式的机会，以便使类风湿关节炎患者的治疗效果最大化。
